Table 5.
Probabilities of COVID-19 progression according to the final logistic model.
| CD8+ NKG2A+ T Cell MFI | ||
|---|---|---|
| ≤2054 * | >2054 | |
| No clinical risk factor † | 0.0% | 0.1% |
| Diabetes only | 0.2% | 3.3% |
| Obesity only | 0.1% | 1.1% |
| Lung involvement only ‡ | 0.1% | 1.1% |
| Diabetes + obesity | 3.2% | 31.9% |
| Diabetes + lung involvement | 3.1% | 31.1% |
| Obesity + lung involvement | 1.1% | 13.2% |
| Diabetes + obesity + lung involvement | 30.6% | 86.2% |
* Cut-off for 90% sensitivity. † Clinical risk factors included in the model are diabetes, obesity, and significant lung involvement on admission. ‡ Oxygen saturation ≤93% or >50% lung involvement on computed tomography examination. MFI, mean fluorescent intensity; NKG2A, natural killer group 2 member A.